Related Experiment Video
Updated: Aug 6, 2026
11:53
Cecal Ligation Puncture Procedure
Published on: May 7, 2011
Tobramycin therapy for lethal sepsis in the dog
Critical Care Medicine
|July 1, 1986
Summary
Comparing single-dose versus multiple-dose tobramycin (TOB) antibiotic therapy for lethal sepsis in dogs, multiple doses combined with methylprednisolone sodium succinate (MPSS) significantly improved survival rates and reduced E. coli levels.
Area of Science:
- Pharmacology
- Infectious Diseases
- Veterinary Medicine
Background:
- Sepsis is a life-threatening condition often caused by bacterial infections.
- Aminoglycoside antibiotics, such as tobramycin (TOB), are used to treat severe bacterial infections.
- The optimal dosing strategy and potential adjunctive therapies for lethal sepsis remain critical research areas.
Purpose of the Study:
- To evaluate the antimicrobial effectiveness and survival impact of single-dose versus multiple-dose tobramycin (TOB) therapy.
- To assess the influence of adjunctive methylprednisolone sodium succinate (MPSS) on treatment outcomes in lethal sepsis.
- To determine the relationship between tobramycin serum concentrations and survival in a canine sepsis model.
Main Methods:
- Adult dogs were experimentally infected with Escherichia coli to induce lethal sepsis.
- Five treatment groups were established: no treatment, single-dose TOB, multiple-dose TOB, single-dose TOB with MPSS, and multiple-dose TOB with MPSS.
- Survival rates, E. coli blood levels, and serum markers of renal function (urea nitrogen and creatinine) were monitored.
Main Results:
- Multiple-dose tobramycin regimens, particularly when combined with methylprednisolone sodium succinate, resulted in significantly higher survival rates (83%) compared to single-dose TOB (17%) or no treatment (0%).
- All tobramycin-treated groups demonstrated reduced E. coli blood levels compared to controls within 4 hours.
- High trough serum TOB concentrations were correlated with mortality, while very low levels were associated with recovery.
Conclusions:
- Multiple-dose tobramycin therapy, especially when combined with methylprednisolone sodium succinate, is more effective in improving survival for lethal sepsis than single-dose therapy.
- Therapeutic drug monitoring is crucial, as high trough serum tobramycin levels may be detrimental, while low levels indicate effective bacterial clearance.
- This study provides valuable insights into optimizing aminoglycoside antibiotic and corticosteroid use in severe sepsis management.
